Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05318131 · ClinicalTrials.gov registry record · NA

Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer

A NA study of Prostate Cancer, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05318131 is a NA study of Prostate Cancer that has completed, run by NYU Langone Health. The registered enrollment target is 50 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05318131, a NA study of Prostate Cancer, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The primary objectives of this study are to examine sleep, exercise, and nutrition in prostate cancer.

Conditions Studied

Prostate Cancer

Interventions

  • OTHER Sleep and Lifestyle Advice Website
  • OTHER Surveys and Sleep Monitors

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-08-30
Est. Completion 2023-10-12
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05318131

The ClinicalTrials.gov registry entry for NCT05318131 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (92% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Sleep and Lifestyle Advice Website is the first listed.

NCT05318131 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05318131 about?

NCT05318131 is a clinical study titled "Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer". The primary objectives of this study are to examine sleep, exercise, and nutrition in prostate cancer.

What is the current status of trial NCT05318131?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2022-08-30. Estimated completion is 2023-10-12.

What conditions does trial NCT05318131 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT05318131?

The interventions under investigation include: Sleep and Lifestyle Advice Website (OTHER), Surveys and Sleep Monitors (OTHER).

Who is sponsoring clinical trial NCT05318131?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05318131 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.